Trade in substandard and falsified medicines
According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical capacity and poor governance contribute to th...
| Autors principals: | , , |
|---|---|
| Altres autors: | |
| Format: | Book section |
| Idioma: | English |
| Publicat: |
Nomos
2022
|